A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/7088 (2006.01) A61P 25/00 (2006.01) A61P 31/00 (2006.01)
Patent
CA 2538245
Randomer phosphorothioate oligonucleotide compositions have been described that inhibit PrPc conversion to PrPcs with a high level of potency. Pharmaceutical compositions or kits containing such compounds, and methods of using such compounds in the treatment, control, or prevention of prion diseases are also described.
L'invention concerne des composés agissant contre les maladies à prions, des compositions pharmaceutiques et des trousses contenant de tels composés, et des procédés d'utilisation de ces composés dans le traitement, la régulation ou la prévention de maladies à prions.
Juteau Jean-Marc
Vaillant Andrew
Norton Rose Or S.e.n.c.r.l. S.r.l./llp
Replicor Inc.
LandOfFree
Oligonucleotides targeting prion diseases does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Oligonucleotides targeting prion diseases, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Oligonucleotides targeting prion diseases will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1413335